Proceeds will fund planned further clinical development of its lead asset, OXU-001, for the treatment of diabetic macular edema (DME), as well as accelerating the development of its early-product pipeline. Checkout PrimeXBT
Source: https://infomeddnews.com/oxular-raises-37-million/
Oxular Raises $37 Million
Date: